SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-18-302148
Filing Date
2018-10-19
Accepted
2018-10-18 18:43:58
Documents
11

Document Format Files

Seq Description Document Type Size
1 424B4 d669557d424b4.htm 424B4 1834552
2 GRAPHIC g669557g05t30.jpg GRAPHIC 148095
3 GRAPHIC g669557g22b30.jpg GRAPHIC 90793
4 GRAPHIC g669557g22e79.jpg GRAPHIC 79492
5 GRAPHIC g669557g31g64.jpg GRAPHIC 46377
6 GRAPHIC g669557g37n50.jpg GRAPHIC 98388
7 GRAPHIC g669557g39h59.jpg GRAPHIC 61351
8 GRAPHIC g669557g47y30.jpg GRAPHIC 79851
9 GRAPHIC g669557g63g73.jpg GRAPHIC 122121
10 GRAPHIC g669557g76k16.jpg GRAPHIC 76509
11 GRAPHIC g669557g82y45.jpg GRAPHIC 24891
  Complete submission text file 0001193125-18-302148.txt   2976552
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-227474 | Film No.: 181129091
SIC: 2834 Pharmaceutical Preparations